For investors interested in our Q2 roadshow covering New York, Boston, Princeton, Chicago, San Diego, and San Francisco, BIORCHESTRA Co., Ltd.'s #RNAi update covers:
✨ In-vivo progress on our neurodegenerative diseases franchise and proprietary IV-formulated RNAi research in #Alzheimer's and #Parkinson's
✨ Status of our #ALS program FDA IND pathway
✨ Licensing negotiations in #CNS, #INHBE/ #MAFLD, and #Glaucoma
✨ Our bridge round syndicate and NYSE / NASDAQ pathway timing
To those requesting one-on-ones through LinkedIn, email davidoxley@biorchestra.com for slots.
Bramalea Partners, PJT Partners, Perella Weinberg, William Blair Investment Banking, Jefferies, Leerink Partners, Nomura, Cain Brothers, CITIC Securities Company Limited, CITIC CLSA Forums, UBS, Oppenheimer & Co. Inc., Wells Fargo Corporate & Investment Banking, Mikael Dolsten Guggenheim Partners, Outcome Capital, Brian Doyle, Michael Bardi, Michael Zhang, Veet Misra, Cantor Fitzgerald, Noël Brown, Samuel Siu, CPA, RBC Capital Markets, John C. Reed, Novo Holdings, Lilly Asia Ventures 礼来亚洲基金, Richard A. Gonzalez, Sumitomo Mitsui Banking Corporation – SMBC Group, #pfizercolleague, Centerview Partners, Morgan Stanley USA, Citi, Bank of America Business, Greenhill & Co., Evercore, Rothschild & Co., Moelis & Company, New York Stock Exchange, Nasdaq Exchange
34
1 Comment